0000899243-18-010747.txt : 20180425 0000899243-18-010747.hdr.sgml : 20180425 20180425202422 ACCESSION NUMBER: 0000899243-18-010747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180423 FILED AS OF DATE: 20180425 DATE AS OF CHANGE: 20180425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROGERS MICHAEL W CENTRAL INDEX KEY: 0001244159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53057 FILM NUMBER: 18775694 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS INC STREET 2: ONE MARINA PARK DRIVE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 BUSINESS PHONE: (513) 985-1920 MAIL ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-23 0 0001422142 Aerpio Pharmaceuticals, Inc. ARPO 0001244159 ROGERS MICHAEL W C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD, SUITE 420 CINCINNATI OH 45242 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 3.59 2018-04-23 4 A 0 144000 0.00 A 2028-04-23 Common Stock 144000 144000 D Options exercisable as to 1/4th on the first anniversary of the vesting start date and an additional 1/48th monthly thereafter until the fourth anniversary of the vesting start date. /s/ Amoli Pandya, Attorney-in-Fact 2018-04-25